Kathleen E McKee
Overview
Explore the profile of Kathleen E McKee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Griffith G, Mehta N, Lamotte G, McKee K, Suttman E, Haus J, et al.
J Parkinsons Dis
. 2025 Feb;
:1877718X241308813.
PMID: 39973503
Background: Endurance exercise improves aerobic capacity (VO) and motor symptoms in people with early Parkinson's disease (PD). Some people with PD exhibit signs of chronotropic incompetence (CI), which may impact...
2.
Lamotte G, McKee K, Luthra N, Corcos D
J Parkinsons Dis
. 2024 Aug;
14(6):1139-1146.
PMID: 39093080
Orthostatic hypotension (OH) is the most common manifestation of cardiovascular autonomic dysfunction in Parkinson's disease. In this viewpoint, we discuss five practical questions regarding OH in Parkinson's disease: 1) How...
3.
McKee K, Knighton A, Veale K, Martinez J, McCann C, Anderson J, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Apr;
17(5):e010477.
PMID: 38567507
Background: Faster delivery of tPA (tissue-type plasminogen activator) results in better health outcomes for eligible patients with stroke. Standardization of stroke protocols in emergency departments (EDs) has been difficult, especially...
4.
Earl T, Jridi A, Thulin P, Zorn M, McKee K, Mitrovich K, et al.
Clin Auton Res
. 2024 Mar;
34(1):117-124.
PMID: 38429568
Purpose: We investigated the effect of levodopa on postural blood pressure changes in individuals with Parkinson disease (PD) with (PD) and without neurogenic OH (PD). Methods: We performed a prospective...
5.
Corcos D, Lamotte G, Luthra N, McKee K
J Parkinsons Dis
. 2024 Jan;
14(3):609-617.
PMID: 38189710
There is compelling evidence that exercise must be part of main line therapy for people with Parkinson's disease. In this viewpoint, we outline the four key components of exercise: aerobic...
6.
Patterson C, Joslin E, Gil A, Spigle W, Nemet T, Chahine L, et al.
Trials
. 2022 Oct;
23(1):855.
PMID: 36203214
Background: To date, no medication has slowed the progression of Parkinson's disease (PD). Preclinical, epidemiological, and experimental data on humans all support many benefits of endurance exercise among persons with...
7.
McKee K, Gilbert R, Spigle W, Tilley B, Corcos D
Mov Disord
. 2022 Aug;
37(10):1990-1995.
PMID: 35929651
No abstract available.
8.
Ryan S, McKee K, Londono-Sanchez L, Dougherty S, Singhal A
Neurohospitalist
. 2022 Apr;
12(2):231-240.
PMID: 35419121
Background: Morbidity and Mortality (M&M) conferences are widespread but vary in goals and methodology. Some focus on clinical enigmas while an increasing number utilize quality improvement (QI) tools to effect...
9.
McKee K, Johnson R, Chan J, Wills A
Brain Behav
. 2021 Feb;
11(4):e02053.
PMID: 33559973
Background: Efficacy of exercise to improve motor symptoms in Parkinson's Disease (PD) has been established in multiple clinical trials. The Pedaling for Parkinson's ™ (PFP) program is an existing community-based...
10.
McKee K, Tull A, Carmen M, Edgman-Levitan S
J Patient Exp
. 2021 Jan;
7(6):931-936.
PMID: 33457523
Initiatives to mitigate physician burnout and improve patient experience occur largely in isolation. At the level of the department/division, we found lower physician burnout was associated with a more positive...